RCM
ACHN

RA Capital Management’s Achillion Pharmaceuticals ACHN Stock Holding History

RA Capital Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-585,890
Closed -$1.69M – 35
2017
Q4 		$1.69M Sell
585,890
-13,047,330
-96% -$47.4M 0.14% 27
2017
Q3 		$61.2M Hold
13,633,220
– – 5.53% 5
2017
Q2 		$62.6M Hold
13,633,220
– – 7.18% 4
2017
Q1 		$57.4M Hold
13,633,220
– – 7.04% 4
2016
Q4 		$56.3M Buy
13,633,220
+1,600,000
+13% +$8.51M 7.98% 4
2016
Q3 		$97.5M Hold
12,033,220
– – 10.05% 2
2016
Q2 		$93.9M Hold
12,033,220
– – 13% 2
2016
Q1 		$92.9M Buy
12,033,220
+810,327
+7% +$5.93M 11.87% 2
2015
Q4 		$121M Sell
11,222,893
-510,922
-4% -$4.64M 11.98% 1
2015
Q3 		$81.1M Buy
11,733,815
+1,787,818
+18% +$14.6M 11.64% 1
2015
Q2 		$88.1M Buy
9,945,997
+1,738,467
+21% +$16.4M 8.86% 2
2015
Q1 		$80.9M Buy
8,207,530
+1,507,530
+23% +$18.8M 8.04% 2
2014
Q4 		$82.1M Hold
6,700,000
– – 8.82% 3
2014
Q3 		$66.9M Sell
6,700,000
-15,786,007
-70% -$147M 7.9% 4
2014
Q2 		$170M Sell
22,486,007
-880,000
-4% -$3.51M 17.21% 1
2014
Q1 		$76.9M Hold
23,366,007
– – 5.51% 5
2013
Q4 		$77.6M Buy
23,366,007
+8,908,946
+62% +$25.9M 9.03% 2
2013
Q3 		$43.7M Buy
14,457,061
+7,001,859
+94% +$48M 4.56% 8
2013
Q2 		$61M Buy
+7,455,202
New +$56.9M 8.09% 3

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RA Capital Management's ACHN Position: Q1 2018 in Review

RA Capital Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2018, closing a stake of 585,890 shares — an estimated $1.69M sold.

RA Capital Management first reported a position in ACHN in Q2 2013 and held it in 19 quarters. The position peaked at $170M in Q2 2014. 127 funds tracked by Wall St. Rank hold ACHN as of Q1 2018.

  • RA Capital Management reported no remaining Achillion Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • RA Capital Management sold 585,890 Achillion Pharmaceuticals shares in Q1 2018, an estimated $1.69M.
  • RA Capital Management first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 19 quarters.
  • RA Capital Management's Achillion Pharmaceuticals position peaked at $170M in Q2 2014.
  • 127 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2018.

Based on RA Capital Management's 13F filing for Q1 2018, filed 15 May 2018.